Developer docs
API playgroundTry for free, no card

Search company profiles

Lima Corporate

Full company profile

uuid0009rdn

Namestring
Lima Corporate
Legal namestring
LimaCorporate S.p.A.
Company typeenum
Private
Founded yearint
1945
Descriptiontext

LimaCorporate S.p.A. was an Italian orthopedic reconstruction company headquartered in Italy (with US operations referenced via Arlington), founded in 1945. The company specialized in hip and knee replacement implants and related reconstructive solutions, serving hospitals, surgical centers, and orthopedic surgeons conducting joint replacement and orthopedic reconstruction procedures. Its functional value proposition centered on advanced implant materials and reconstructive technologies aimed at improving surgical outcomes and patient recovery, with demand drivers tied to the global rise in joint replacement procedures and robotic-assisted surgery adoption.

LimaCorporate monetized its offerings through the standard orthopedic medical device commercial model: B2B quote-based procurement of implants through hospital purchasing channels, typically structured via Group Purchasing Organization (GPO) contracts. Pricing was not publicly disclosed, consistent with industry norms for surgical implants. Customer segmentation was horizontal, addressing hospitals/surgical centers as the primary use-case buyer and orthopedic surgeons as the clinical decision-maker persona. Specific product names, deeper technical specifications, and a detailed product portfolio are not disclosed in the available source data.

In January 2024, LimaCorporate was acquired by Enovis Corporation, a US-based medical technology company, for approximately EUR 800 million. Following the acquisition, LimaCorporate was integrated into Enovis's global orthopedic reconstruction segment and is no longer operating as an independent entity; its former digital properties now resolve to Enovis Surgical's website gateway. The acquisition was primarily motivated by Enovis's goal of expanding its hip and knee replacement portfolio and international orthopedic reconstruction footprint.

Short descriptiontext

LimaCorporate is an Italian orthopedic reconstruction company specializing in hip and knee replacement implants, serving hospitals, surgical centers, and orthopedic surgeons; it was acquired by Enovis Corporation in January 2024.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersArlington, United States
HQ citystring
Arlington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
orthopedic implants, hip replacement, knee replacement, orthopedic reconstruction, joint replacement
Industry4 codes
1Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryYes
2Hip & Knee Reconstruction (Arthroplasty)
CodeHLAKALAHPrimaryNo
3Orthopedic Surgery (Operative Orthopedics)
CodeHLAKALACPrimaryNo
43D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Medical Devices
Social media profiles1 record
Cost components5 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Lima Corporate designs, manufactures, and distributes orthopedic reconstruction implants primarily for hip and knee replacement procedures. The company's portfolio includes advanced implant materials and surgical technologies aimed at improving patient recovery times and surgical outcomes. Lima Corporate serves hospitals, surgical centers, and orthopedic surgeons globally as part of Enovis Corporation's orthopedic reconstruction business.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Lima Corporate (S.p.A.) is an Italy-based orthopedic reconstruction company specializing in hip and knee replacement implants. The company was acquired by US-based Enovis Corporation in January 2024. No specific product names or detailed product portfolio information are available in the provided source data.

Product and service3 records
1Hip Replacement Implants
CategoryOrthopedic Implants
Description

Specialized hip replacement implant systems designed for orthopedic reconstruction procedures. These implants are sold to hospitals, surgical centers, and orthopedic surgeons performing total hip replacement surgeries, with a focus on advanced implant materials to support quicker patient recovery and improved clinical outcomes.

2Knee Replacement Implants
CategoryOrthopedic Implants
Description

Specialized knee replacement implant systems designed for orthopedic reconstruction procedures. These implants are sold to hospitals, surgical centers, and orthopedic surgeons performing total knee replacement surgeries, leveraging advanced implant materials and supporting robotic-assisted surgical solutions for improved patient outcomes.

3Orthopedic Reconstruction Implant Systems
CategoryOrthopedic Reconstruction Devices
Description

Comprehensive orthopedic reconstruction implant systems supporting joint replacement and trauma procedures. These systems are sold to hospitals, surgical centers, and orthopedic surgeons for use in orthopedic reconstruction surgeries, addressing the growing demand for advanced implant technologies in joint replacement procedures.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Exactech is a US-based orthopedic implant company focused on hip, knee, shoulder, and extremities reconstruction, with comparable surgeon-focused sales channels. It is a directly comparable mid-market peer in joint replacement implants.

TypeBroad incumbent
Description

NuVasive (now part of Globus Medical) is a broad orthopedic incumbent focused on spine but with adjacent presence in enabling technologies and reconstruction-adjacent markets. It is a broad incumbent peer in the orthopedic device space.

TypeDirect peer
Description

Stryker is one of the largest global orthopedic medical device companies, with a leading hip and knee reconstruction implant portfolio (Mako robotic-assisted surgery platform) and a broad hospital sales channel. It is a directly comparable large-cap peer for LimaCorporate's hip and knee replacement business.

TypeOthers
Description

DJO is a sister division of Enovis Corporation and LimaCorporate's new corporate sibling within the same parent, focused on orthopedic bracing, surgical implants, and recovery products. It is an ecosystem/portfolio peer rather than a direct competitor.

TypeEmerging player
Description

ConforMIS specializes in patient-specific, custom 3D-printed knee implants, closely aligned with the advanced implant materials and patient-specific themes cited in LimaCorporate's value proposition. It is an emerging, niche peer overlapping in knee reconstruction.

TypeDirect peer
Description

Waldemar Link is a German-based, privately held orthopedic implant manufacturer specializing in hip and knee reconstruction, comparable in size and Europe-centric focus to LimaCorporate. It is a directly comparable European peer.

TypeDirect peer
Description

Smith+Nephew operates a significant hip and knee reconstruction franchise (Journey, Legion, and Polarstem) and is a direct mid-to-large cap competitor to LimaCorporate in joint replacement implants.

TypeDirect peer
Description

DePuy Synthes, J&J's orthopedics franchise, offers the Attune knee system and a broad hip reconstruction portfolio with strong global hospital access. It is a directly comparable peer in the hip and knee implant market.

TypeDirect peer
Description

Zimmer Biomet is a top-tier global orthopedic reconstruction company with a deep hip and knee implant portfolio (including the Persona knee and Rosa robotics platform). It is a directly comparable large-cap peer competing head-to-head with LimaCorporate in joint replacement.

TypeDirect peer
Description

B. Braun's Aesculap division manufactures hip and knee implants and surgical instruments, with a global hospital footprint. It is a directly comparable peer in orthopedic reconstruction implants.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lima Corporate

Orthopedic Medical Deviceslimacorporate.com

LimaCorporate is an Italian orthopedic reconstruction company specializing in hip and knee replacement implants, serving hospitals, surgical centers, and orthopedic surgeons; it was acquired by Enovis Corporation in January 2024.

What Lima Corporate does

LimaCorporate S.p.A. was an Italian orthopedic reconstruction company headquartered in Italy (with US operations referenced via Arlington), founded in 1945. The company specialized in hip and knee replacement implants and related reconstructive solutions, serving hospitals, surgical centers, and orthopedic surgeons conducting joint replacement and orthopedic reconstruction procedures. Its functional value proposition centered on advanced implant materials and reconstructive technologies aimed at improving surgical outcomes and patient recovery, with demand drivers tied to the global rise in joint replacement procedures and robotic-assisted surgery adoption.

LimaCorporate monetized its offerings through the standard orthopedic medical device commercial model: B2B quote-based procurement of implants through hospital purchasing channels, typically structured via Group Purchasing Organization (GPO) contracts. Pricing was not publicly disclosed, consistent with industry norms for surgical implants. Customer segmentation was horizontal, addressing hospitals/surgical centers as the primary use-case buyer and orthopedic surgeons as the clinical decision-maker persona. Specific product names, deeper technical specifications, and a detailed product portfolio are not disclosed in the available source data.

In January 2024, LimaCorporate was acquired by Enovis Corporation, a US-based medical technology company, for approximately EUR 800 million. Following the acquisition, LimaCorporate was integrated into Enovis's global orthopedic reconstruction segment and is no longer operating as an independent entity; its former digital properties now resolve to Enovis Surgical's website gateway. The acquisition was primarily motivated by Enovis's goal of expanding its hip and knee replacement portfolio and international orthopedic reconstruction footprint.

Lima Corporate firmographics

Firmographics
Name
Lima Corporate
Legal name
LimaCorporate S.p.A.
Website
https://limacorporate.com
Company type
Private
Founded year
1945
Operating status
Acquired
Headcount range
501–1,000 employees
Short description
LimaCorporate is an Italian orthopedic reconstruction company specializing in hip and knee replacement implants, serving hospitals, surgical centers, and orthopedic surgeons; it was acquired by Enovis Corporation in January 2024.
Ownership category
akta.pro rank

Lima Corporate industry classification

Industry
Product category
Orthopedic Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
akta.pro secondary industries
Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH), Orthopedic Surgery (Operative Orthopedics) (HLAKALAC), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

Keywords

  • Orthopedic implants
  • Hip replacement
  • Knee replacement
  • Orthopedic reconstruction
  • Joint replacement

Where Lima Corporate is headquartered

Location

Headquarters

HQ city
Arlington
HQ country
United States
HQ region
North America

Markets served

Lima Corporate business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Lima Corporate product offering

Product offering

Core offering

Lima Corporate designs, manufactures, and distributes orthopedic reconstruction implants primarily for hip and knee replacement procedures. The company's portfolio includes advanced implant materials and surgical technologies aimed at improving patient recovery times and surgical outcomes. Lima Corporate serves hospitals, surgical centers, and orthopedic surgeons globally as part of Enovis Corporation's orthopedic reconstruction business.

Product overview

Lima Corporate (S.p.A.) is an Italy-based orthopedic reconstruction company specializing in hip and knee replacement implants. The company was acquired by US-based Enovis Corporation in January 2024. No specific product names or detailed product portfolio information are available in the provided source data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Hip Replacement Implants Specialized hip replacement implant systems designed for orthopedic reconstruction procedures. These implants are sold to hospitals, surgical centers, and orthopedic surgeons performing total hip replacement surgeries, with a focus on advanced implant materials to support quicker patient recovery and improved clinical outcomes.
  • Knee Replacement Implants Specialized knee replacement implant systems designed for orthopedic reconstruction procedures. These implants are sold to hospitals, surgical centers, and orthopedic surgeons performing total knee replacement surgeries, leveraging advanced implant materials and supporting robotic-assisted surgical solutions for improved patient outcomes.
  • Orthopedic Reconstruction Implant Systems Comprehensive orthopedic reconstruction implant systems supporting joint replacement and trauma procedures. These systems are sold to hospitals, surgical centers, and orthopedic surgeons for use in orthopedic reconstruction surgeries, addressing the growing demand for advanced implant technologies in joint replacement procedures.

Companies that use Lima Corporate

Customer profile

Segments2 records

Ideal customer profiles2 records

Lima Corporate technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Lima Corporate partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Lima Corporate competitors and assessment

Company assessment

Direct peers

  • Exactech: Exactech is a US-based orthopedic implant company focused on hip, knee, shoulder, and extremities reconstruction, with comparable surgeon-focused sales channels. It is a directly comparable mid-market peer in joint replacement implants.
  • Stryker: Stryker is one of the largest global orthopedic medical device companies, with a leading hip and knee reconstruction implant portfolio (Mako robotic-assisted surgery platform) and a broad hospital sales channel. It is a directly comparable large-cap peer for LimaCorporate's hip and knee replacement business.
  • Waldemar Link: Waldemar Link is a German-based, privately held orthopedic implant manufacturer specializing in hip and knee reconstruction, comparable in size and Europe-centric focus to LimaCorporate. It is a directly comparable European peer.
  • Smith+Nephew: Smith+Nephew operates a significant hip and knee reconstruction franchise (Journey, Legion, and Polarstem) and is a direct mid-to-large cap competitor to LimaCorporate in joint replacement implants.
  • Johnson & Johnson (DePuy Synthes): DePuy Synthes, J&J's orthopedics franchise, offers the Attune knee system and a broad hip reconstruction portfolio with strong global hospital access. It is a directly comparable peer in the hip and knee implant market.
  • Zimmer Biomet: Zimmer Biomet is a top-tier global orthopedic reconstruction company with a deep hip and knee implant portfolio (including the Persona knee and Rosa robotics platform). It is a directly comparable large-cap peer competing head-to-head with LimaCorporate in joint replacement.
  • B. Braun Aesculap: B. Braun's Aesculap division manufactures hip and knee implants and surgical instruments, with a global hospital footprint. It is a directly comparable peer in orthopedic reconstruction implants.

Broad incumbents

  • NuVasive: NuVasive (now part of Globus Medical) is a broad orthopedic incumbent focused on spine but with adjacent presence in enabling technologies and reconstruction-adjacent markets. It is a broad incumbent peer in the orthopedic device space.

Others

  • DJO (Enovis Surgical): DJO is a sister division of Enovis Corporation and LimaCorporate's new corporate sibling within the same parent, focused on orthopedic bracing, surgical implants, and recovery products. It is an ecosystem/portfolio peer rather than a direct competitor.

Emerging players

  • ConforMIS: ConforMIS specializes in patient-specific, custom 3D-printed knee implants, closely aligned with the advanced implant materials and patient-specific themes cited in LimaCorporate's value proposition. It is an emerging, niche peer overlapping in knee reconstruction.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Lima Corporate social profiles

Digital presence

Lima Corporate financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lima Corporate leadership team

Management profile

Number of profiles

Profiles2 records

Lima Corporate funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lima Corporate M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lima Corporate

What does Lima Corporate do?

Lima Corporate designs, manufactures, and distributes orthopedic reconstruction implants primarily for hip and knee replacement procedures. The company's portfolio includes advanced implant materials and surgical technologies aimed at improving patient recovery times and surgical outcomes. Lima Corporate serves hospitals, surgical centers, and orthopedic surgeons globally as part of Enovis Corporation's orthopedic reconstruction business.

Is Lima Corporate a public or private company?

Lima Corporate is a private company. It is classified as corporate owned and is currently acquired.

When was Lima Corporate founded?

Lima Corporate was founded in 1945. It employs 501 to 1,000 people.

Where is Lima Corporate based?

Lima Corporate is headquartered in Arlington, United States, in the North America region.

Who are Lima Corporate's main competitors?

Direct peers on record are Exactech, Stryker, Waldemar Link, Smith+Nephew, Johnson & Johnson (DePuy Synthes), Zimmer Biomet and B. Braun Aesculap. NuVasive is listed as a broad incumbent. DJO (Enovis Surgical) is listed as an others. ConforMIS is listed as an emerging player.

Does Lima Corporate have an API?

No public API is recorded for Lima Corporate.

What industry is Lima Corporate in?

Lima Corporate's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAKALAH, Hip & Knee Reconstruction (Arthroplasty). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireSports Medicine Market to reach USD 15.60 Billion by 2035 at 7.29% CAGRThe global sports medicine market is projected to grow from USD 7.72 billion in 2025 to USD 15.60 billion by 2035, a CAGR of 7.29%. Growth is driven by rising sports participation, minimally invasive techniques, and ambulatory surgery centre expansion, with knee injuries accounting for 32.7% of applications.The Motley Fool4 Top Growth Stocks Worth Buying Under $100 TodayFour industrial and healthcare stocks under $100 are highlighted for growth: Enovis, Insteel Industries, Mueller Water Products, and Proto Labs. Enovis reported 11% Q1 2026 reconstructive sales growth, Insteel posted 7.5% Q2 sales up, Mueller reaffirmed guidance, and Proto Labs is pivoting to production manufacturing.openPR.comEmerging Growth Trends Driving the Expansion of the Bio-Implants MarketThe bio-implants market is projected to grow from its current size to $228.53 billion by 2030, representing a compound annual growth rate of 10.7%, driven by investments in regenerative medicine, 3D-printed implants, and personalized healthcare solutions. In January 2024, US-based Enovis Corporation acquired Italy-based LimaCorporate S.p.A. to expand its orthopedic portfolio and joint reconstruction offerings. In July 2023, UK-based Smith+Nephew launched its REGENETEN Bioinductive Implant in India, reporting an 86% relative reduction in re-tear rates for rotator cuff disease compared to conventional surgery.GlobeNewswireEnovis Announces First Quarter 2024 ResultsEnovis reported first-quarter 2024 net sales of $516 million, up 27% on a reported basis, with adjusted EPS of $0.50. The company closed its acquisition of Lima and updated its 2024 full-year revenue forecast to $2.06-2.16 billion.GlobeNewswireEnovis Completes Acquisition of LimaCorporate S.p.AEnovis Corporation has completed the acquisition of LimaCorporate S.p.A., a privately held global orthopedic leader. The transaction expands Enovis' portfolio with 3D printed Trabecular Titanium implants and revision shoulder solutions, bringing its reconstruction segment revenues to $1 billion.PR NewswireEQT Private Equity to sell LimaCorporate, one of the global leaders in joint replacement solutionsEQT Private Equity, along with co-shareholders, has agreed to sell LimaCorporate to NYSE-listed Enovis Corporation in a strategic combination that will create a global leader in the orthopaedic industry. LimaCorporate, an Italian orthopaedic implant manufacturer founded in 1945, generated EUR 249 million in revenues in 2022 and sells products in 49 countries with more than 130,000 implants delivered annually. The transaction, expected to close in early 2024 subject to customary conditions and approvals, was advised by Goldman Sachs, Morgan Stanley, Mediobanca, Latham & Watkins, and PwC.PR NewswireEQT PRIVATE EQUITY TO SELL LIMACORPORATE TO ENOVIS: THE ITALIAN SITE IN SAN DANIELE DEL FRIULI WILL REMAIN THE FULCRUM OF PRODUCTION, BENEFITING FROM NEW INVESTMENTSEQT Private Equity announced the sale of orthopaedic implant manufacturer LimaCorporate to NYSE-listed Enovis, creating a global leader in the orthopaedic industry. The transaction, expected to close in early 2024, will see LimaCorporate's production site in San Daniele del Friuli remain central to operations while benefiting from new investments and Enovis's global network.GlobeNewswireEnovis to Acquire LimaCorporate S.p.A.Enovis Corporation announced a definitive agreement to acquire LimaCorporate S.p.A., a privately held global orthopedic leader, in a transaction valued at approximately €800 million. The deal involves a €700 million cash payment and €100 million in Enovis common stock, with completion expected in early 2024 subject to regulatory approvals. The acquisition aims to create a reconstruction business with roughly $1 billion in annual revenue and generate approximately $40 million in cost synergies by the third year post-closing.PR NewswireEQT PRIVATE EQUITY TO SELL LIMACORPORATE TO ENOVIS: THE ITALIAN SITE IN SAN DANIELE DEL FRIULI WILL REMAIN THE FULCRUM OF PRODUCTION, BENEFITING FROM NEW INVESTMENTSEQT Private Equity has announced the sale of its portfolio company LimaCorporate to the NYSE-listed medical technology firm Enovis. The transaction, expected to close in early 2024, will integrate LimaCorporate into Enovis to create a global leader in the orthopaedic industry while retaining production at its Italian headquarters. EQT and LimaCorporate management highlighted that the combination leverages complementary portfolios and new investments in additive manufacturing capabilities.EnovisEnovis to Acquire LimaCorporate S.p.A.Enovis Corporation announced a definitive agreement to acquire LimaCorporate S.p.A., a global orthopedic leader, in a transaction valued at approximately €800 million. The deal combines the two companies to create a reconstruction business with roughly $1 billion in annual revenue and is expected to generate significant cost synergies. The acquisition is scheduled for completion in early 2024, pending regulatory approvals.